Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 12:17 PM
Ignite Modification Date:
2025-12-26 @ 12:17 PM
NCT ID:
NCT07274800
Eligibility Criteria:
Inclusion Criteria:• Histological diagnosis of breast adenocarcinoma
* Prior breast conservative surgery negative resection margins (3 mm)
* Pathological stage pT1-pT2, N0-1, pT3-N0, M0
* No macroscopic evidence of distant metastases at diagnosis
* Age 18-80 years
* Female patients
* Normal hematological and biochemical laboratory tests
* Written informed consent was obtained from all patients
Exclusion Criteria: • Patients underwent mastectomy.
* Locally advanced disease pT4, N2,3.
* Positive surgical margins
* Prior thoracic radiation
* Synchronous second primary tumor
* Distant metastases
* Pregnancy
* Presence of a concomitant psychiatric disorder precluding an aware informed consent.
* Age \>80 years
* Low risk patient meeting all the following criteria (more than or equal 65 years, PT1, grade 1 or 2, +ER, -Her2nu, N0, M0).
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07274800
Study Brief:
Protocol Section:
NCT07274800